| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |